BIOMERIEUX
About BIOMERIEUX
bioMérieux is a French multinational biotechnology company and a world leader in in vitro diagnostics, providing solutions that determine the source of disease and contamination to improve patient health and ensure consumer safety. The company specializes in three main areas: microbiology, immunoassays, and molecular biology. Its diagnostic solutions are primarily used in hospital and private clinical laboratories for the diagnosis of infectious diseases, cancer screening, and monitoring cardiovascular emergencies.
Beyond clinical applications, bioMérieux also applies its expertise to industrial microbiological control, helping manage contamination risks in agri-food, pharmaceutical, and cosmetic products throughout the production chain. The company is strongly committed to addressing major public health challenges such as antimicrobial resistance (AMR) and sepsis, developing high-performance solutions to combat these threats. bioMérieux is actively integrating artificial intelligence (AI) into its diagnostic tools, with partnerships focused on developing AI models for genomic analysis, improving the prediction of antibiotic resistance, and enhancing critical care through earlier prediction of sepsis-related shock.
Physicians rely on bioMérieux’s diagnostic solutions to quickly and reliably determine pathologies or sources of contamination, providing crucial information for optimal patient care and guiding appropriate treatment decisions. The company invests significantly in research and development to innovate in pathogen detection and identification, aiming to reduce time to results and expand its portfolio with high medical value parameters.
Focus Areas
Business Intelligence
| Key Investors | Institut Mérieux (main shareholder) |
| Partnerships | Mila - Quebec Artificial Intelligence Institute (AI for diagnostics, antibiotic resistance), Quanterix (ultrasensitive, multiplex immunoassays), Altesa BioSciences (Phase 2B COPD Clinical Trial), OhioHealth (Antimicrobial Stewardship Center of Excellence) |
| Acquisitions | Accellix (Jan 2026), Day Zero Diagnostics (June 2025), SpinChip (Jan 2025), LUMED (Jan 2024), Specific Technologies (Apr 2022), Invisible Sentinel (Feb 2019), Astute Medical (Apr 2018), BioFire Diagnostics Inc. (2014) |
| Technology | Cloud-native (e.g., EPISEQ SARS-COV-2, BIOMÉRIEUX VISION SUITE), Molecular Biology (BIOFIRE® FilmArray®, BIOFIRE® SPOTFIRE® System, Extreme PCR technology), Mass Spectrometry (VITEK® MS PRIME), Automated Identification and Antimicrobial Susceptibility Testing (VITEK® COMPACT PRO, VITEK® 2 Advanced Expert System™), Machine Learning for genomic analysis and diagnostic insights, Digital and AI tools merging bioinformatics and genomics. |
| FDA Clearances | Numerous (e.g., Vitek Compact Pro ID/AST system in March 2025, BIOFIRE® SPOTFIRE® System and Respiratory (R) Panel in Feb 2023, BIOFIRE® SPOTFIRE® Respiratory (R) Panel Mini in April 2023, BIOFIRE® FILMARRAY® Gastrointestinal (GI) Panel Mid in Feb 2025) cleared products (estimated) |
What the Web Says
BIOMERIEUX is a global company specializing in in-vitro diagnostics and microbiology solutions. Employee reviews generally highlight strong benefits, job security, and a positive mission focused on public health. However, some employees express concerns about management, opportunities for advancement, and work-life balance in certain departments. Product reviews for their diagnostic systems, such as the BioFire FilmArray Torch and VITEK MS PRIME, are largely positive, emphasizing ease of use, accuracy, and excellent customer support.
Overall: PositiveStrengths
- Excellent job security
- Strong benefits package (including health insurance and 401k match)
- Meaningful mission in public health
- Collaborative and friendly coworkers
- Easy-to-use and accurate diagnostic products
- Good customer service and support for products
Limitations
- Slow corporate bureaucracy
- Some issues with management and favoritism
- Limited opportunities for advancement in certain roles
- Long hours and repetitive tasks in manufacturing (historically 12-hour shifts)
- Website and software interfaces can be difficult to navigate
- Compensation perceived as below average by some employees
Based on reviews from: Comparably, Indeed.com, Zippia, Reddit, Handshake, Select Science, American Pharmaceutical Review
Last updated: 2026-07-20
Videos
News, demos, and interviews about BIOMERIEUX.
Videos load interactively. If none appear, search YouTube for BIOMERIEUX →
Press & Coverage
Frequently Asked Questions
Related Companies
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]
MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]
allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]